Syringes for sophisticated drug products

Syringes for sophisticated drug products
Product Description

Biotech derived drug products are characterized by several specific requirements. Some are highly viscous and, in individual cases, tend to interact with silicone oil or, for example, tungsten residues from syringe production. Gerresheimer therefore offers the “metal-free” production avoiding the use of metal pins. The special silicone oil treatment (baked-on RTF®) for the reduction of free silicone oil creates a perfect primary packaging material for these sophisticated drug products. Innovative closure systems like Gx TELC® or Gx TERNS® complete our offering. We can also offer syringes with thin-walled cannulas that ease the administration of the often highly viscous medications thanks to their improved flow properties.

Gerresheimer AG

  • DE
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
CMO/CDMO
Contract Service
Manufacturer/Innovator
Packaging supplier/manufacturer
Primary activities
Animal Health
Biopharmaceutical
Contract Manufacturer
Medical Devices
Packaging & drug delivery
Specifications

Gerresheimer AG

  • DE
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
CMO/CDMO
Contract Service
Manufacturer/Innovator
Packaging supplier/manufacturer
Primary activities
Animal Health
Biopharmaceutical
Contract Manufacturer
Medical Devices
Packaging & drug delivery

More Products from Gerresheimer AG (24)

  • Primary Packaging Glass - RTF vials

    Product Primary Packaging Glass - RTF vials

    Gx® RTF vials enhance flexibility by facilitating packaging needs from clinical stage to industrialization with the common goal to minimize customer product risks and optimize total cost of ownership. Gerresheimer combines the competencies in converting glass tubes to serum/ injection vials and tra...
  • Primary Packaging Glass - Gx® Elite Glass Vials

    Product Primary Packaging Glass - Gx® Elite Glass Vials

    The Gx Elite vials are the result of a careful product development process spanning several years. The highly shatter-resistant vials are extremely durable and free of cosmetic defects. They also boast an incredibly robust structure, while their resistance to delamination protects the drug inside. Simp...
  • Primary Packaging Glass - Vials

    Product Primary Packaging Glass - Vials

    Our tubular vials product range includes clear and amber vials in glass types I, II and III from 0.6 to 100 ml. We produce different designs, with or without blowback, according to industry standards or to individual specifications. As a special feature we offer sterile RTF® vials based on its long e...
  • Primary Packaging Glass - Cartridges

    Product Primary Packaging Glass - Cartridges

    Gerresheimer produces high-quality cartridges with fill volumes ranging from 1.5 to 3.0 ml (sizes up to 10.0 ml on request) for various pharmaceutical applications. Our product range covers clear and amber cartridges made of borosilicate glass of hydrolytic class I. Individual options, such as an a...
  • Primary Packaging Glass - Ampoules

    Product Primary Packaging Glass - Ampoules

    Gerresheimer offers a broad portfolio of highly competitive pharmaceutical ampoules in type I pharma glass. Our standard range covers ampoules made of flint and amber glass with filling capacities from 1 to 30 ml. These include straight-stem, funnel-type and closed ampoules of ISO types B, C and D ...
  • Primary Packaging -     Gx® prefillable syringes

    Product Primary Packaging - Gx® prefillable syringes

    Prefillable glass syringes in bulk and "ready-to-fill" format, type 1 glass, filling volumes of 0.5 ml to 5.0 ml, luer cone and luer lock syringes, needle syringes, silicone-oil reduces Gx Baked-on RTF® syringes, metal-free Gx RTF® syringes, innovative syringe components, round and cut finger flange, most ...
  • Gx RTF® metal-free glass syringes

    Product Gx RTF® metal-free glass syringes

    One problem associated with syringe use is that traces of tungsten or other metals occasionally leave residue behind in the bore when the syringe cone is shaped. Gerresheimer developed a production technology registered for patent where the pin used to shape the cone is made of a special ceramic. So we can...
  • Gx RTF® ClearJect® Polymer syringes

    Product Gx RTF® ClearJect® Polymer syringes

    Gx RTF® ClearJect® syringes are made from COP (Cyclo Olefin Polymer). They are glue-free as the cannula is not glued in, but is instead insert-molded during the injection molding process, no aggregation due to metal or tungsten residues, high viscosity silicone oil for reduced particles, minimal extractabl...
  • Drug Delivery Systems - Inhalers

    Product Drug Delivery Systems - Inhalers

    In close cooperation with leading pharmaceuticals companies, Gerresheimer Medical Systems has been developing and producing powder inhalers, capsule inhalers and nebulizers for the treatment of respiratory illnesses like asthma, COPD (Chronic Obstructive Pulmonary Disease) and cystic fibrosis for m...
  • Drug Delivery Devices - Pen injectors

    Product Drug Delivery Devices - Pen injectors

    In the pen injector product segment, our core competence lies both in high quality, reusable pen injectors and in economically produced disposable pens, including glass cartridges. Our many years of experience in the segment of „lancing devices and lancets" is especially advantageous here. We activel...
  • Velocity® Vials

    Product Velocity® Vials

    Make the fill & finish process up to 50% more efficient with vials with a Velocity® coating. A major problem in the fill & finish process of conventional borosilicate glass vials is the friction caused by glass-to-glass and glass-to-metal contacts. Frictional resistance reduces the t...
  • Drug Delivery Systems - Autoinjector Gx Inbeneo

    Product Drug Delivery Systems - Autoinjector Gx Inbeneo

    Building bridges from drugs to patients
    Single-use autoinjector Platform technology Patient-centric approach
    Single use autoinjector for subcutaneous application
    • Pre-pressurized, cartridge-based system • No contact between the needle and the drug during storage (dry needle system...

Gerresheimer AG resources (13)

  • News Gerresheimer predicts weight-loss drug deals to account for 4% of yearly growth

    Dietmar Siemssen, CEO of German primary packaging manufacturer Gerresheimer, states that approximately 4% of the company’s revenue growth each year to come from deals with drugmakers of weight loss and diabetes products, particularly GLP-1 class drugs. 
  • Brochure Primary Packaging Plastics - Solid dosages

    Gerresheimer Primary Packaging Plastics specializesin the widely varied spectrum of pharmaceuticalplastic packaging within solid, liquid andophthalmic applications, plastic vials and plasticbottles for personal care.
  • Video Exploring Platform Solutions: From Primary Packaging to Advanced On-Body Drug Delivery Systems

    Holger Krenz will be speaking at CPHI Milan about Gerresheimer’s platform solutions for primary packaging and drug delivery systems. His presentation will focus on the product benefits of the Gx Elite performance level which are the ideal packaging components for reliable functionality of drug delivery systems.
  • Video Gx Elite RTF® Glass and Polymer Syringes – First Choice for Demanding Biologics

    Ensure highest product quality and lowest cosmetic defects Accelerate drug development by most comprehensive data packages Create tailored system options with state-of-the-art technologies and components Offer best fit for demanding drug formulations by addressing bio-pharmaceutical requirements
  • Webinar Gerresheimer's Product Platforms: Designated Quality Levels to Secure Best in Class Performance in Multiple Application Fields & Demanding Disease Areas

    "As a solution provider with a unique & dedicated product portfolio​, Gerresheimer is continuously exploring options to better accommodate their customers along the drug development and drug LCM journey. With its newly installed product platforms, Gerresheimer will be combining outstanding quality levels with specific product requirements in dedicated application fields and disease areas. From dental care over hematology, vaccines, diabetes and metabolism disorders into complex and more demanding areas such as Cell Gene Therapy, ophthalmology and oncology ... Gerresheimer will be able to support even better in finding the best containment solution for their specific application. Picking one example, we'll elaborate on our offering in the ophthalmology field ..."
  • Webinar Keynote Address

    How can device and packaging innovation influence patient ability and motivation to use their treatment?" With examples from research of how patients learn and become motivated, and how industry can use these processes to influence patient outcomes. Patients learn through a mixture of stimuli and learning processes, these stimuli can be adopted into device design and packaging to enhance the patient's feelings about their medication. Presently many patients using complex devices, like inhalers, make critical errors which entails repeated re-training. This presentation looks at innovative ways of embedding learning, that could be adopted by future device and packaging design.
  • Webinar Lightning Talk - Blister Packs - How is the Past shaping the Future?

    What are blister packs, and why are they so important? How have they changed over the years, and where are they heading? This presentation will consider a history of how blister packs have benefitted the supply of medicines to patients worldwide, and how they are continuing to evolve within an increasingly sustainable landscape.
  • Webinar Lightning Talk - Next-Gen Wearable Devices

    Wearables can take different shapes and sizes and are revolutionizing the way we monitor, treat, and manage health conditions. In this short deep dive, we will look at innovative wearable technologies and how they enable data collection and analysis, patient centric care, personalized medicine and more.
  • Webinar Partner Presentation - Gerresheimer

    Overcoming challenges when developing subcutaneous drug delivery devices that empower patient self-administration. The trend in parenteral patient therapy has been moving towards the home-care setting for some time as it empowers patient independence. However, home administration brings additional requirements when developing a delivery device, and these are constantly evolving. Patient safety is always paramount, but usability is another critical factor, as well as sustainability and connectivity to support patient adherence. The challenge is to design a device to meet as many requirements as possible that can be ready on the market within 4-8 years. In this presentation we will discuss Gerresheimer’s mission of “innovating for a better life” and how we apply this when developing solutions that respond to the needs of patients, our pharmaceutical industry customers, and the environment, today and into the future.
  • Webinar Lightning Talk - Opportunities and Challenges in Connected Drug Delivery

    The talk explores the current integration of digital health in drug delivery and various opportunities that it presents. Delving into the landscape of drug delivery, we examine the rise of connected devices, emphasizing the delicate balance between technology and compassionate care. This session also addresses real-world challenges like adoption, satisfaction, regulatory, and security considerations. Be part of the conversation on overcoming these challenges.
  • Webinar Sensory Exploration: A Journey into Patient-Centric Perception

    From sight, touch, taste, and smell to hearing, the five senses allow the body to take everything in. Research shows that the more senses are used, the better the memory is gathered, and the process enhanced. How does this theory apply to device development, design conception, and patient experience?